Source author record

Cinzia Mortarino

Cinzia Mortarino appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
2topics
2close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

The role of swabs in modeling the COVID-19 outbreak in the most affected regions of Italy

The daily fluctuations in the released number of Covid-19 cases played a big role both at the beginning and in the most critical weeks of the outbreak, when local authorities in Italy had to decide whether to impose a lockdown and at which level. Public opinion was focused on this information as well, to understand how quickly the epidemic was spreading. When an increase/decrease was communicated, especially a large one, it was not easy to understand if it was due to a change in the epidemic evolution or if it was a fluctuation due to other reasons, such as an increase in the number of swabs or a delay in the swab processing. In this work, we propose a nonlinear asymmetric diffusion model, which includes information on the daily number of swabs, to describe daily fluctuations in the number of confirmed cases in addition to the main trend of the outbreak evolution. The class of diffusion models has been selected to develop our proposal, as it also allows estimation of the total number of confirmed cases at the end of the outbreak. The proposed model is compared to six existing models, among which the logistic and the SIRD models are used as benchmarks, in the five most affected Italian regions.

preprint2016arXiv

Modeling competition between two pharmaceutical drugs using innovation diffusion models

The study of competition among brands in a common category is an interesting strategic issue for involved firms. Sales monitoring and prediction of competitors' performance represent relevant tools for management. In the pharmaceutical market, the diffusion of product knowledge plays a special role, different from the role it plays in other competing fields. This latent feature naturally affects the evolution of drugs' performances in terms of the number of packages sold. In this paper, we propose an innovation diffusion model that takes the spread of knowledge into account. We are motivated by the need of modeling competition of two antidiabetic drugs in the Italian market.